Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GTE possible 3-4 bagger
GTE - OIL deal coming soon between Russia and Saudis
GTE - best OIL play at .25 - insider buying - positive earnings - best risk to reward ratio all IMO
I checked most other oil plays
Get in it to win it.
FOMO
DEAL coming soon Russia and Saudi's
It has to, thye both want it SOON
One target - Target Price 4.72
https://www.finviz.com/quote.ashx?t=gte
OILU at low -3x's oil-OPEC cut?
OILU at low -3x's oil-OPEC cut?
OILU
As I posted I got out at $1.29 after getting in at $1.23. So I missed the run up to over $2, but now at this $1.42, it seems to be a nice re-entry point as there "should" be support at this level?
I never intended to hold it long term, but I did like it more than for day trading.
If you are long, I think it is a good one.
Good luck to you.
Yes and if so $1 support level.
Agree $1.50 target for.JAGX - After a breakout from that .60 level.
Happy New Year
I did too, but I did predict it. Can't win them all.
GTE in $1.20s as I said. It just took a few weeks longer.
What I said on 11/12:
"GTE Bottom is in. Triple bottom and lots of insider buying, with free cash flow predicted in 2020, and many catalysts. This is a solid company and I think $1.20 - $1.40 is possible in the weeks ahead with little downside.
IMO
I am in at $1.07."
Should be today on news OPGN.
OPGN filling gap? But $2 possible.
On SYBX it was lower after the week than I even thought. I thought it would stay in that $2.60 to $2.80 range and you thought $4.00, so our chart readings were both off, but hey it happens.
Yankee fans finally got Cole in our stockings.
Yankee/Dodger world series would be awesome.
So far, but a week isn't up yet.
BUY TVIX? impeachment = volatility (year low)
Impeachment=volatilty? TVIX good play at year low?
IMPEACHMENT process = volatility?? TVIX BUY?
BET VOLATILITY with impeachment. BUY TVIX?
TVIX at year low. BUY?
BUY NOW 54.25
Yes both (CREG & CORV) nice entry points.
CORV pipeline at .39. "Correvio Pharma Corp is a Canada-based specialty pharmaceutical company. It provides brands that meet the needs of acute care physicians and patients. It develops, acquires and commercializes brands for the in-hospital, acute care market segment. The following is its portfolio of approved and marketed brands: Xydalba, for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP); Brinavess for the conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as well as Esmocard and Esmocard Lyo, a short-acting betablocker used to control rapid heart rate in a number of cardiovascular indications. Its pipeline of product candidates includes Trevyent, a drug device combination that is designed to deliver treprostinil."
Up 8% pre market.
CORV pipeline at .39. "Correvio Pharma Corp is a Canada-based specialty pharmaceutical company. It provides brands that meet the needs of acute care physicians and patients. It develops, acquires and commercializes brands for the in-hospital, acute care market segment. The following is its portfolio of approved and marketed brands: Xydalba, for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP); Brinavess for the conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as well as Esmocard and Esmocard Lyo, a short-acting betablocker used to control rapid heart rate in a number of cardiovascular indications. Its pipeline of product candidates includes Trevyent, a drug device combination that is designed to deliver treprostinil."
CORV up 8% pre market.
CORV Neutral by H.C. Wainwright. Not a sell at least.
At .39 neutral is almost a buy. LOL
Good luck all.
BUY when all are SELLING.
Good opportunity here IMO.
.50 soon IMO. 25% gain
CORV .39 If you love gaps this is for you? LOL
LOL
Ok so on SYBX. I will say no on the $4.00 plus in a week. I can see the gap at around $4.55 to be a factor, and I do believe gaps get filled most times, but just not in a week's time with this one.
I will however say it "settles" around the $2.60-$2.80 level
(so where it is now basically) in the next week.
If you hold good luck for that $4.00?
I think this is my last post allowed?
How many does a non-subscriber get AF?
I thought is was maybe 15?
I say Angels. BUT if I am right I won't say it? LOL
Yes. Almost out of posts for day. Doctors orders. LOL
Will do.
Maybe Dodgers go for Bumgarner now?
But I got COLE for Christmas.
RELAX is what doctor said. Hard for me. LOL